FDA offering more regulatory flexibility to promote innovation during COVID-19

Dr. Amy Abernethy, principal deputy commissioner at the U.S. FDA, discusses the FDA's role in balancing innovation, regulation and safety during the coronavirus pandemic.
By HIMSS TV
05:08 pm
Share

MobiHealthNews:

The latest news in digital health delivered daily to your inbox.

Thank you for subscribing!
Error! Something went wrong!